These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral. Al Wakeel JS, Shaheen FA, Mathew MC, Abou Zeinab HM, Al Alfi A, Tarif NM, Al Mousawi MS, Mahmoud TS, Alorrayed AS, Fagir EA, Dham RS, Shaker DS. Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205 [Abstract] [Full Text] [Related]
3. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A, Piñeyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez-Silva M, Waksman N, E Salazar-Leal M, Luján-Rangel R. Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203 [Abstract] [Full Text] [Related]
5. The pharmacokinetics of equoral versus neoral in stable renal transplant patients: a multinational multicenter study. Masri MA, Haberal M, Rizvi A, Stephan A, Bilgin N, Naqvi A, Barbari A, Kamel G, Zafar N, Emiroğlu R, Colak T, Manzoor K, Matha V, Kamarad V, Rizk S, Itany AR, Shehedeh I. Transplant Proc; 2004 Sep; 36(1):80-3. PubMed ID: 15013306 [Abstract] [Full Text] [Related]
11. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis. Erkko P, Granlund H, Nuutinen M, Reitamo S. Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300 [Abstract] [Full Text] [Related]
12. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH. Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [Abstract] [Full Text] [Related]
13. Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients. Hibberd AD, Trevillian PR, Roger SD, Wlodarczyk JH, Stein AM, Bohringer EG, Milson-Hawke SM. Transplantation; 2006 Mar 15; 81(5):711-7. PubMed ID: 16534473 [Abstract] [Full Text] [Related]
17. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients. Sinescu I, Lopes HV, Foschi D, Jen LH, Oliani C. Eur Rev Med Pharmacol Sci; 1999 Mar 15; 3(1):11-8. PubMed ID: 10710824 [Abstract] [Full Text] [Related]
20. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group. Keown P, Niese D. Kidney Int; 1998 Sep 15; 54(3):938-44. PubMed ID: 9734620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]